
Ramya Ramaswami
@ramya_ramaswami
An oncologist caring for people living with HIV #HIVOnc @theNCI|Trained in the 🇬🇧 from many cultures 🇸🇬🇮🇳 now in 🇺🇸 |Former @NEJM fellow| Views are mine
ID: 1575844861
07-07-2013 18:57:23
2,2K Tweet
1,1K Takipçi
1,1K Takip Edilen




People with HIV are diagnosed with lung cancer 10-15 years earlier than the general population. We need to better understand the risk factors and optimize lung cancer screening for PWH. Our team, led by Randi M. Williams, PhD, MPH, will delve into this topic! Grateful for funding from

📢📗𝐍𝐄𝐖 𝐁𝐎𝐎𝐊 𝐀𝐍𝐍𝐎𝐔𝐍𝐂𝐄𝐌𝐄𝐍𝐓! 📘📢 After nearly 7 years in creation, my new book 𝐖𝐈𝐂𝐊𝐄𝐃 𝐏𝐑𝐎𝐁𝐋𝐄𝐌𝐒: 𝐇𝐨𝐰 𝐭𝐨 𝐄𝐧𝐠𝐢𝐧𝐞𝐞𝐫 𝐚 𝐁𝐞𝐭𝐭𝐞𝐫 𝐖𝐨𝐫𝐥𝐝 will be out on March 26! W. W. Norton & Company




🇬🇧What does the U.K. national anthem have to do with fire safety? 🔥 I’m delighted to debut as a host for the Queen Elizabeth Prize for Engineering podcast Create the Future. In my first episode, I have a red-hot conversation w/ Luke Bisby & Jose Torero Royal Academy of Engineering Peanut & Crumb podcasts.apple.com/us/podcast/cre…




🚾 What happens after you flush? I get my hands dirty for the next episode of the Queen Elizabeth Prize for Engineering #podcast “Create the Future.” Exploring the #engineering origins of public health, why sanitation is the "Other AI" & why the mundane is magnificent for maintenance. podcasts.apple.com/gb/podcast/the…


Hot off the press from Kate Lurain Ramya Ramaswami TAO Elad Sharon Denise Whitby Important new data showing high and durable activity for anti-PD1 in HIV-KS! CITN12: Pembro in HIV-Associated Kaposi Sarcoma | JCO ascopubs.org/doi/10.1200/JC…



Ramya Ramaswami National Cancer Institute et al (A11505) tested abemaciclib, a CDK4/6 inhibitor, in advanced KS, and found that a majority of patients (84%) had significant reduction in the size & extent of their KS

Phase I/II trial evaluates the safety and efficacy of abemaciclib in patients with HIV-associated and HIV-negative Kaposi sarcoma. Dr Ramya Ramaswami (Ramya Ramaswami) highlights the importance of the findings in the full interview ecancer.org/en/video/12382… #ASCO25